OncoMed Signs Second Cancer Stem Cell Partner; This Time It's Bayer
By
The Pink Sheet Daily / Email the Author / “The Pink Sheet” DAILY Jun. 17, 2010
Word Count: 865 / Article # 14100617004
Executive Summary
Deal with Bayer to discover and develop Wnt pathway therapies follows 2007 deal with GSK focused on Notch pathway.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.